Skip to main content
Sign in Register
Question no. 63033

What pharmacokinetic parameter determines the loading dose_____________?

Select your answer for: What pharmacokinetic parameter determines the loading dose_____________?
Show answer

Answer: A. Volume of distribution

Explanation

Volume of distribution relates the total amount of drug in the body to its measured plasma concentration. Calculating a proper loading dose requires knowing this parameter to achieve target therapeutic concentrations instantly. Drugs with large volumes of distribution require significantly higher initial loading doses to saturate peripheral tissues. Loading doses allow clinicians to attain therapeutic drug levels rapidly without waiting for multiple half-lives. Clearance determines the maintenance dose rate required to replace eliminated drug molecules steadily over time. Pharmacokinetic parameters guide safe and effective dosing strategies across various clinical care settings daily.

Emergency medicine situations frequently demand loading doses of critical medications like antiarrhythmics or anticonvulsants. Underdosing can occur if the volume of distribution is ignored when calculating initial bolus drug amounts. Clinical pharmacists use these mathematical principles to individualize drug therapy for critically ill patients. Clearance determines maintenance dosing requirements rather than calculating the initial loading dose of a medication. Rate of administration dictates how fast a drug infusion is given rather than its distribution characteristics. Half-life determines the time required for plasma concentrations to decrease by half during elimination phases.

Subject
Medical
Category
Medical
Topic
—
Difficulty
medium

Related questions

Q1. Which agent is classified as a long-acting beta-2 agonist ?

Select your answer for: Which agent is classified as a long-acting beta-2 agonist ?
Show answer

Answer: B. Salmeterol

Salmeterol binds with high affinity to beta-2 adrenergic receptors located in airways. Its lipophilic side chain allows prolonged attachment to receptor exosite regions. This extended duration of action provides sustaine...

Q2. The vast majority of pharmaceutical drugs cross biological membranes via____________?

Select your answer for: The vast majority of pharmaceutical drugs cross biological membranes via____________?
Show answer

Answer: A. Passive diffusion

Most pharmaceutical drugs are small lipophilic molecules capable of crossing lipid bilayers easily. They move across cell membranes down their electrochemical concentration gradients without requiring energy expenditure....

Q3. Lidocaine exerts its antiarrhythmic properties through what mechanism_____________?

Select your answer for: Lidocaine exerts its antiarrhythmic properties through what mechanism_____________?
Show answer

Answer: B. Decreasing cardiac excitability

Lidocaine blocks voltage-gated sodium channels in cardiac muscle membranes during depolarization. Reducing sodium influx decreases the rate of cellular depolarization and membrane excitability. This stabilization prevent...

Q4. The Michaelis constant (Km value) provides an indication of______________?

Select your answer for: The Michaelis constant (Km value) provides an indication of______________?
Show answer

Answer: D. Affinity

The Michaelis constant represents the substrate concentration required to reach maximum velocity. A lower constant indicates higher binding affinity between the enzyme and substrate molecules. Conversely, higher values r...

Q5. The primary mode of action for local anaesthetics involves the inhibition of_____________?

Select your answer for: The primary mode of action for local anaesthetics involves the inhibition of_____________?
Show answer

Answer: C. Only sensory fibres

Local anesthetics preferentially block sensory nerve fibers before motor fibers due to differences in fiber diameter and myelination.

Q6. Identify the pharmaceutical agent responsible for inducing hirsutism, gynecomastia, and menstrual irregularities following long-term administration______________?

Select your answer for: Identify the pharmaceutical agent responsible for inducing hirsutism, gynecomastia, and menstrual irregularities following long-term administration______________?
Show answer

Answer: C. Spironolactone

Spironolactone is a potassium-sparing diuretic possessing strong steroid receptor antagonist properties. It blocks androgen receptors and inhibits testosterone synthesis, leading to significant endocrine side effects. Lo...